Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.

Autor: Costa Clemens SA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Institute of Global Health, University of Siena, Siena, Italy., Weckx L; Department of Pediatrics, Universidade Federal de São Paulo, São Paulo, Brazil., Clemens R; International Vaccine Institute, Seoul, Korea., Almeida Mendes AV; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil; General Medicine, Hospital São Rafael, Salvador, Brazil; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., Ramos Souza A; Universidade Federal de São Paulo, São Paulo, Brazil., Silveira MBV; Universidade Federal de São Paulo, São Paulo, Brazil., da Guarda SNF; General Medicine, Hospital São Rafael, Salvador, Brazil; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil; Department of Pediatrics, Universidade Federal da Bahia, Salvador, Brazil., de Nobrega MM; Universidade Federal de São Paulo, São Paulo, Brazil., de Moraes Pinto MI; Universidade Federal de São Paulo, São Paulo, Brazil., Gonzalez IGS; Universidade Federal de São Paulo, São Paulo, Brazil., Salvador N; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., Franco MM; General Medicine, Hospital São Rafael, Salvador, Brazil; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., de Avila Mendonça RN; General Medicine, Hospital São Rafael, Salvador, Brazil; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., Queiroz Oliveira IS; General Medicine, Hospital São Rafael, Salvador, Brazil; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., de Freitas Souza BS; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil; Gonçalo Moniz Institute, Fiocruz, Salvador, Brazil., Fraga M; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., Aley P; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Cantrell L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Dejnirattisai W; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Liu X; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Mongkolsapaya J; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Supasa P; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Screaton GR; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK., Lambe T; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK., Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Pollard AJ; NIHR Oxford Biomedical Research Centre, Oxford, UK. Electronic address: andrew.pollard@paediatrics.ox.ac.uk.

Publikováno v: Lancet (London, England) [Lancet] 2022 Feb 05; Vol. 399 (10324), pp. 521-529. Date of Electronic Publication: 2022 Jan 21.

Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants.

Autor: Wang, Xue-Jun¹ (AUTHOR), Yao, Lin¹ (AUTHOR), Zhang, Hong-Yun² (AUTHOR), Zhu, Ka-Li^1,3 (AUTHOR), Zhao, Jing² (AUTHOR), Zhan, Bing-Dong⁴ (AUTHOR), Li, Yi-Ke^1,5 (AUTHOR), He, Xue-Juan^1,5 (AUTHOR), Huang, Cong¹ (AUTHOR), Wang, Zhuang-Ye⁶ (AUTHOR), Jiang, Ming-Dong⁶ (AUTHOR), Yang, Peng¹ (AUTHOR), Yang, Yang¹ (AUTHOR), Wang, Guo-Lin¹ (AUTHOR), Wang, Sheng-Qi¹ (AUTHOR), Dai, Er-Hei⁷ (AUTHOR), Gao, Hui-Xia⁷ (AUTHOR) swysjb@163.com, Ma, Mai-Juan^1,3,5 (AUTHOR) mjma@163.com

Publikováno v: Genome Medicine. 12/29/2022, Vol. 14 Issue 1, p1-13. 13p.

Impact of a delayed second dose of mRNA vaccine (BNT162b2) and inactivated SARS-CoV-2 vaccine (CoronaVac) on risks of all-cause mortality, emergency department visit, and unscheduled hospitalization.

Autor: Wong, Carlos King Ho^1,2,3 (AUTHOR), Xiong, Xi¹ (AUTHOR), Lau, Kristy Tsz Kwan¹ (AUTHOR), Chui, Celine Sze Ling^3,4,5 (AUTHOR), Lai, Francisco Tsz Tsun^1,3 (AUTHOR), Li, Xue^1,3,6 (AUTHOR), Chan, Esther Wai Yin^1,3 (AUTHOR), Wan, Eric Yuk Fai^1,2,3 (AUTHOR), Au, Ivan Chi Ho¹ (AUTHOR), Cowling, Benjamin John^3,5,7 (AUTHOR), Lee, Cheuk Kwong⁸ (AUTHOR), Wong, Ian Chi Kei^1,3,9 (AUTHOR) wongick@hku.hk

Publikováno v: BMC Medicine. 10/24/2022, Vol. 20 Issue 1, p1-12. 12p.

Homologous and Heterologous Covid-19 Booster Vaccinations Against SARS-CoV-2 Infection in the Elderly.

Autor: Acer Ö; Department of Medical Microbiology, Medical Faculty, Siirt University, 56100, Siirt, Türkiye. oacer21@gmail.com., Genç Bahçe Y; Microbiology Laboratory, Siirt Training and Research Hospital, 56100, Siirt, Türkiye., Özüdoğru O; Department of Internal Medicine, Medical Faculty, Erzincan Binali Yıldırım University, 24100, Erzincan, Türkiye.

Publikováno v: Current microbiology [Curr Microbiol] 2024 May 13; Vol. 81 (7), pp. 171. Date of Electronic Publication: 2024 May 13.